Clinical Trials Directory

Trials / Completed

CompletedNCT05529888

Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin.

Serum Homocysteine Level in Acne Patients Before and After Oral Isotretinoin

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Aswan University · Academic / Other
Sex
All
Age
15 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Serum homocysteine level in Acne patients before and after oral Isotretinoin and Correlation between serum level of homocysteine in acne patients before and after Oral isotretinoin treatment

Detailed description

Acne vulgaris is a common chronic inflammatory disease of the skin. It is found in about 80% of young adults and adolescents. It is a disease that affects the pilosebaceous units of the skin and may result in inflammatory or non-inflammatory lesions,Oral isotretinoin (13-cis-retinoic acid) is the only drug that counteracts all the pathogenetic mechanisms that contribute to the development of acne The standard dose of isotretinoin is 0.5 to 1 mg/kg per day for 4 months to a cumulative dose of 120-140 mg/kg is effective in the management of acne vulgaris The scope of our study is to detect serum homocysteine level in acne patient befor and after oral isotrtinoin treatment

Conditions

Interventions

TypeNameDescription
DRUGIsotretinoinIsotretinoin is a vitamin-A derivative for treatment of moderate to severe acne used in a dose from 20-40 mg for 3 months duration

Timeline

Start date
2020-12-15
Primary completion
2021-12-15
Completion
2021-12-15
First posted
2022-09-07
Last updated
2022-09-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05529888. Inclusion in this directory is not an endorsement.